Novartis Ag (NVS) Shares Outstanding (2009 - 2026)

Novartis Ag has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $1.9 billion for Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) fell 3.39% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (down 3.39% YoY), while the FY2025 annual figure was $1.9 billion, down 3.39% from the prior year.
• Shares Outstanding (Entity) came in at $1.9 billion for Q4 2025 at Novartis Ag, down from $2.0 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $2.2 billion in Q4 2021 to a low of $1.9 billion in Q4 2025.
• Average Shares Outstanding (Entity) over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) retreated 0.97% in 2021 and declined 5.16% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $2.2 billion in 2021, then declined by 5.16% to $2.1 billion in 2022, then decreased by 3.57% to $2.0 billion in 2023, then dropped by 3.37% to $2.0 billion in 2024, then declined by 3.39% to $1.9 billion in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.9 billion in Q4 2025, $2.0 billion in Q4 2024, and $2.0 billion in Q4 2023.